Thursday, August 28, 2014
Serrapeptase Dissolves Arterial Plaque
Discovered in the early 1970’s, this proteolytic enzyme was isolated from the Serratia species of bacteria located in the intestines of silkworms. Serrapeptase, also called serratiopeptidase, is truly a superior enzyme that provides strong, healthful properties. Today Serrapeptase is used all over Europe and Asia in clinical settings. It has the ability to break down non-living tissue in the body.
Serrapeptase is perhaps one of the world’s most exciting enzymes being studied in regard to its wide variety of clinical applications. Currently, especially in Europe and Asia, it is clinically used for many, many negative health conditions. One of the most well-known proponents for this enzyme was the German physician, Dr. Hans Nieper. He had great success supplementing with serrapeptase to promote normal heart and circulatory system health.
How Does Serrapeptase Work?
Serrapeptase is an immunologically active enzyme. It can bind itself to the alpha 2 macroglobulin in our plasma where it is shielded from the immune system while retaining its enzymatic activity, and in this way it is transferred to the sites where it is needed in the body. It is this same type of powerful yet specific action that allows silkworms to eat its own protective cocoon, digest it without any side effects and fly away. Amazingly, serrapeptase has the distinct ability to digest only non-living tissue allowing the old toxic layers that clog the digestive system and the lining of our arteries to dissolve. This is one reason why its so good at keeping arterial deposits from building up after heart surgery.
Health Benefits of Serrapeptase
Dr. Nieper found that Serrapeptase could dissolve blood clots and reduce varicose veins. Other studies from Germany have found that serrapeptase could effectively remove atherosclerotic plaque without hurting any of the healthy cells along the arterial wall.
2. Chronic Redness
Multiple studies confirm it’s resistance to Redness and it has been used for this reason in the reduction of chronic or acute conditions.
3. Helps with Traumatic Injuries
Serrapeptase is widely used in Europe as a supplement for traumatic injury (such as sprains and torn ligaments), as well as the swelling associated with post-surgical patients.
4. Pain, Edema and Swelling
Serrapeptase has been approved as a standard remedy in many European countries for swelling. A double-blind German study on the enzyme found that it could reduce swelling by up to 50% in post-operative patients. Patients taking serrapeptase experienced statistically significant less pain than the control groups and, by the 10th day of the study, all patients taking the serrapeptase were completely pain free.
5. Helps with Cystic Breast Disease
In a double-blind study, Serrapeptase was found to reduce breast pain, breast swelling and induration in 85.7% of the patients taking the supplement. This is related to the fact that the enzyme possesses fibrinolytic, proteolytic and anti-edemic properties.
6. Helps Infections in the Ear, Nose and Throat
In one double-blind study, patients with acute or chronic ear, nose or throat diseases found significant symptom regression with Serrapeptase. The enzyme is able to reduce the viscosity of mucous, thus facilitating drainage.
7. Helps with Carpal Tunnel Syndrome
Recent studies confirm the use of this enzyme for the reduction of symptoms associated with carpal tunnel syndrome.
8. Other Potential Benefits
Serrapeptase is currently being studied and used for a vast array of applications for human health and disease prevention. This includes therapeutic use for nerve damage, Multiple Sclerosis, chronic ear infections, hay fever, lung congestion, swollen glands, laryngitis, rhinitis, chronic pain, arthritis, back and neck pain, diabetes, ulcers, osteoporosis, prostate problems, rheumatoid arthritis, sports injuries (both prevention and recovery), post operative scars and lesions, varicose veins, arterial diseases, angina, blood clots, anti-aging, restoration of healthy fibrin metabolism and reduction in C-Reactive Protein.
How to Read the Units of Measurement for Serrapeptase
Serrapeptase is measured in SUs (Serrapeptase Units). This comes from the Japanese and Korean Pharmacopeias, whereby one unit of Serrapeptase is the activity yielding a product equivalent of 1.0 μg of Tyrosine per minute at pH 9.0 and 37 degrees Celcius on a casein substrate.
Where Can I Find The Best Source of Serrapeptase?
VeganZyme™ contains a 100% vegan form of Serrapeptase cultured from Serratia marcescens. It comes from all vegetarian, non-GMO sources, is kosher certified, gluten free, contains no animal product and is completely suitable for vegetarians and vegans. VeganZyme™ is the most advanced full-spectrum systemic and digestive enzyme formula in the world and is free from fillers and toxic compounds. This formula contains digestive enzymes which help digest fats (lipids), sugars, proteins, carbohydrates, gluten, fruits and vegetables, cereals, legumes, bran, nuts and seeds, soy, dairy and all other food sources. VeganZyme™ may also be used as a systemic enzyme blend to break down excess mucus, fibrin, various toxins, allergens, as well as excess clotting factors throughout your body.
- Dr. Edward F. Group III, DC, ND, DACBN, DCBCN, DABFM
Kee WH, Tan SL, Lee V, Salmon YM. The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trial. Singapore Med J. 1989 Feb;30(1):48-54. Mazzone A, Catalani M, Costanzo M, Drusian A, Mandoli A, Russo S, Guarini E, Vesperini G. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res. 1990 Sep-Oct;18(5):379-88. Kakinuma A, Moriya N, Kawahara K, Sugino H. Repression of fibrinolysis in scalded rats by administration of Serratia protease. Biochem Pharmacol. 1982 Sep 15;31(18):2861-6. Esch PM, Gerngross H, Fabian A. [Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase-- a prospective study]. Fortschr Med. 1989 Feb 10;107(4):67-8, 71-2. German.